Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
41.21
+0.97 (2.41%)
Jul 26, 2024, 4:00 PM EDT - Market closed
BHVN Market Cap
BHVN has a market cap or net worth of $3.64 billion as of July 26, 2024. Its market cap has increased by 113.33% in one year.
Market Cap
3.64B
Enterprise Value
3.38B
1-Year Change
113.33%
Ranking
Category
Stock Price
$41.21
Market Cap Chart
Since October 4, 2022, BHVN's market cap has increased from $297.30M to $3.64B, an increase of 1,123.85%. That is a compound annual growth rate of 299.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 3.55B | 3.46% |
| Dec 29, 2023 | 3.43B | 262.96% |
| Dec 30, 2022 | 946.10M | 218.23% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 3.57B |
| PROCEPT BioRobotics | 3.54B |
| Prestige Consumer Healthcare | 3.52B |
| Alvotech | 3.49B |
| Axonics | 3.47B |
| GoodRx Holdings | 3.41B |
| Arcellx | 3.40B |
| Denali Therapeutics | 3.40B |